☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Decrease
G1 Therapeutics' Cosela (trilaciclib) Receives US FDA's Approval as the First Myeloprotection Therapy for Extensive-Stage Small Ce...
February 15, 2021
Sandoz's Ziextenzo (biosimilar- pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia
November 5, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.